Clinical Trial: The Progressive Supranuclear Palsy Clinical Trial Platform

U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07173803) titled 'The Progressive Supranuclear Palsy Clinical Trial Platform' on Sept. 03.

Brief Summary: The Progressive Supranuclear Palsy Clinical Trial Platform (PTP) is a multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of PSP.

Study Start Date: Dec. 01, 2025

Study Type: INTERVENTIONAL

Condition: Progressive Supranuclear Palsy(PSP)

Intervention: BIOLOGICAL: AADvac1

Active immunotherapy

DRUG: AZP006 (Ezeprogind(R))

Lysosomal targeting therapy

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Adam Boxer

Information provided by (Responsible Party): Adam Boxer, Uni...